By the end of 2026, the global gastric electrical stimulator market is expected to exceed US$ 291.1 million. The increasing availability of novel high-frequency gastric electrical stimulators, as well as a greater emphasis on the treatment of rare diseases such as gastroparesis, are expected to drive the market.
According to the FMI report on the gastric electric stimulators market, sales of gastric electric stimulators are likely to skyrocket in the coming years, owing to an increase in minimally invasive procedures, an increase in reported cases of gastroparesis, and encouraging reimbursement schemes. The increasing prevalence of gastroparesis has been identified as the primary demand generator, making gastric electric stimulators a highly preferred treatment alternative for such difficult diseases.
Request a Sample Report with Table of Contents and Figures@ https://www.futuremarketinsights.com/reports/sample/rep-gb-8992
“Enterra system, a critical medical device which is highly used to treat Gastroparesis has received FDA approval as a humanitarian use device, on the back of its potential to treat or diagnose a disease or condition affecting approx. 4000 individuals annually in the United States. Though conditionally, the American College of Gastroenterology (ACG) also recommends adoption of gastric electric stimulators for individuals with chronic, stubborn nausea and vomiting caused by Gastroparesis. The gastric electric stimulators, like Enterra, is a battery-based gastric neurostimulator, which is usually rooted under the skin in lower abdomen part of the body”, Senior Analyst, FMI.
According to the FMI report on the gastric electric stimulators market, sales of gastric electric stimulators are likely to skyrocket in the coming years, owing to an increase in minimally invasive procedures, an increase in reported cases of gastroparesis, and encouraging reimbursement schemes. The increasing prevalence of gastroparesis has been identified as the primary demand generator, making gastric electric stimulators a highly preferred treatment alternative for such difficult diseases.
High-Frequency Product Type Gaining Colossal Traction
According to the FMI report, high-frequency variants of gastric electric stimulators are gaining significant traction as one of the most compelling product types, as opposed to low-frequency variants of gastric electric stimulators. According to the FMI gastric electric stimulators market report, high-frequency variants of gastric electric stimulators are not only minimally invasive and extremely patient-friendly in terms of insertion, but also have a comparatively longer battery life than low-frequency variants. Furthermore, according to FMI analysis, with over 75% market share in gastric stimulators, high-frequency variants of gastric electric stimulators are likely to improve the Gastroparetic treatment landscape.
Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-8992
Despite the fact that gastric electrical stimulation is the most viable treatment option for chronic drug-refractory nausea and vomiting caused by idiopathic or diabetic gastroparesis, the risks associated with Enterra Therapy remain exceptionally high, limiting the use of gastric electric stimulators.
North America Gastric Electric Stimulators Market Remains Lucrative
According to the FMI gastric electric stimulators report, North America is likely to maintain its market dominance between 2018 and 2026. Growing investments in medical studies and R&D activities, ongoing technological advancements and innovations, and the presence of several leading market players are other key factors paving the way for lucrative opportunities in the gastric electric stimulators market across North America, according to the FMI report.
According to the gastric electric stimulators market report, the global gastric electric stimulators market will remain highly consolidated, with market Mughals accounting for approximately 5o% of global revenue share, owing to their superior product offering and extensive demographic presence. Furthermore, in order to capitalise on the growing demand for gastric electric stimulators, leading market players are planning collaborations and acquisitions of local players in order to strengthen their market presence.
Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-8992
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs